Antibody biomarker for de novo Parkinson disease: attempted validation

Parkinson disease (PD) is a progressive neurodegenerative disease with motor symptoms that result from degeneration of midbrain dopaminergic neurons. Biomarker research seeks to identify the disease during the pre-symptomatic phase, which is a time when therapeutic intervention will be most helpful....

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Na, Simanski, Scott, Islam, Kazi, Hynan, Linda S., Kodadek, Thomas, German, Dwight C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125321/
https://www.ncbi.nlm.nih.gov/pubmed/30211310
http://dx.doi.org/10.1038/s41531-018-0064-2